Skip to main content

Trump Should End the FDA’s 25-Year Cover-Up on the Abortion Pill

Politics
United States
Started February 15, 2026

Mifepristone has not gotten safer; the FDA has just gotten more political

🗳️ Join the conversation
5 statements to vote on • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ statements, 50+ votes
Statements 5/7
Total Votes 0/50
💡 Keep voting and adding statements to unlock consensus insights

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Posted by will Feb 15, 2026
Mifepristone has been proven safe and effective; any claims of a cover-up undermine the trust in our healthcare system and the FDA's rigorous processes.
0 total votes
CLAIM Posted by will Feb 15, 2026
The FDA's approval of mifepristone should be reevaluated to ensure safety standards are upheld, prioritizing women's health above political agendas.
0 total votes
CLAIM Posted by will Feb 15, 2026
The discussion around mifepristone reflects broader societal debates on reproductive rights, necessitating an open dialogue about women's healthcare options.
0 total votes
CLAIM Posted by will Feb 15, 2026
Ending the FDA's oversight on mifepristone could set a dangerous precedent, allowing political influence to dictate medical safety regulations.
0 total votes
CLAIM Posted by will Feb 15, 2026
The debate over mifepristone highlights the need for balanced regulatory practices that consider both safety and access to reproductive healthcare.
0 total votes

💡 How This Works

  • Add Statements: Post claims or questions (10-500 characters)
  • Vote: Agree, Disagree, or Unsure on each statement
  • Respond: Add detailed pro/con responses with evidence
  • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement